Webinar Announcement: 3D Bioprinted Hepatic Patch for Targeted Exosome Delivery in Fatty Liver Disease

脂肪肝疾患における標的エクソソーム送達のための3Dバイオプリント肝パッチをテーマにしたウェビナー告知バナー(講師:Ashok Kumar教授、IIT Kanpur)
             

3D Bioprinted Hepatic Patch for Targeted Exosome Delivery in Fatty Liver Disease

3D Bioprinted Hepatic Patch for Targeted Exosome Delivery in MASLD

Overview

Title
3D Bioprinted Hepatic Patch for Targeted Exosome Delivery in Fatty Liver Disease
Date
December 15, 2025 (Monday)
Time
1:00 p.m. CEST
5:30 p.m. IST
7:00 a.m. EST
*In Japan Standard Time (JST): starts at 9:00 p.m. on the same day
Language
English
Host / Speaker
Prof. Ashok Kumar
Indian Institute of Technology Kanpur
Organizer
CELLINK
More Information / Registration

CELLINK Event Page (Click here to register)

About the Webinar

Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) is a complex metabolic liver disorder that can progress from fat accumulation to inflammation, fibrosis, and eventually hepatocellular carcinoma. Current treatment options focus primarily on lifestyle modification and pharmacological intervention to delay disease progression; however, they cannot regenerate damaged liver tissue. As a result, liver transplantation remains the last resort, but donor scarcity and surgical risks pose significant challenges.

In this webinar, Prof. Ashok Kumar from the Indian Institute of Technology Kanpur will introduce an “off-the-shelf” hepatic patch produced using DLP-based 3D bioprinting technology. This hepatic patch is designed to deliver mesenchymal stem cell–derived exosomes to enable localized and sustained therapeutic activity as well as tissue regeneration.

This session will be highly relevant for researchers, pharmaceutical scientists, and medical professionals interested in novel regenerative approaches for MASLD, the design of 3D-printed scaffolds for exosome delivery, and preclinical findings demonstrating improved liver function and reduced fibrosis.

What You Will Learn

  • Why MASLD requires new regenerative medicine strategies
  • How bioprinted scaffolds enhance exosome stability and controlled release
  • Preclinical findings demonstrating improved liver function and reduced fibrosis

About the Speaker

Portrait of Professor Ashok Kumar, Indian Institute of Technology Kanpur
Professor Ashok Kumar (Indian Institute of Technology Kanpur)

Professor Ashok Kumar is a leading researcher in advanced bioengineering at the Indian Institute of Technology Kanpur, where he also serves as the Head of the Department of Environmental Science and Engineering. Additionally, he is the Director of the IIT Kanpur–La Trobe University Research Academy.

His research focuses on advanced biomaterials and 3D bioprinting technologies for tissue regeneration, with applications in bone repair and peripheral nerve regeneration. Through long-term international collaborations, including with Aalto University, Professor Kumar has significantly contributed to the advancement of biomedical engineering.

Source: CELLINK “3D Bioprinted Hepatic Patch for Targeted Exosome Delivery in Fatty Liver Disease” Webinar Page


About CELLINK

CELLINK, part of the BICO Group, provides cutting-edge 3D cell culture solutions for drug discovery and biomedical research. With bioprinting technology at its core, the company develops platforms that advance translational medicine and research innovation.


コメントは閉じられています。